[go: up one dir, main page]

AU2002224003A1 - Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering - Google Patents

Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Info

Publication number
AU2002224003A1
AU2002224003A1 AU2002224003A AU2400302A AU2002224003A1 AU 2002224003 A1 AU2002224003 A1 AU 2002224003A1 AU 2002224003 A AU2002224003 A AU 2002224003A AU 2400302 A AU2400302 A AU 2400302A AU 2002224003 A1 AU2002224003 A1 AU 2002224003A1
Authority
AU
Australia
Prior art keywords
biological matrices
tissue engineering
decellularizing
acellular
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224003A
Inventor
Gilad E. Amiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002224003A1 publication Critical patent/AU2002224003A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
AU2002224003A 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering Abandoned AU2002224003A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
IL139708 2000-11-15
PCT/IL2001/001060 WO2002040630A2 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Publications (1)

Publication Number Publication Date
AU2002224003A1 true AU2002224003A1 (en) 2002-05-27

Family

ID=11074822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224003A Abandoned AU2002224003A1 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Country Status (3)

Country Link
AU (1) AU2002224003A1 (en)
IL (1) IL139708A0 (en)
WO (1) WO2002040630A2 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4092397B2 (en) * 2002-09-10 2008-05-28 国立循環器病センター総長 Treatment of living tissue for transplantation by applying ultrahigh hydrostatic pressure
US7459154B2 (en) * 2002-12-26 2008-12-02 Cell Genesys, Inc. Methods and reagents for the enhancement of virus transduction in the bladder epithelium
WO2005023321A2 (en) 2003-09-04 2005-03-17 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US7592139B2 (en) 2004-09-24 2009-09-22 Sandia National Laboratories High temperature flow-through device for rapid solubilization and analysis
WO2006073626A2 (en) * 2005-01-05 2006-07-13 The Cleveland Clinic Foundation Method for fixing tissue
EP1863545B1 (en) 2005-03-19 2015-11-18 Cook Biotech, Inc. Prosthetic implants including ECM composite material
WO2006113382A2 (en) 2005-04-15 2006-10-26 Wake Forest University Health Sciences Bioreactor system and method of enhancing functionality of muscle cultured in vitro
EP1719533A1 (en) * 2005-05-04 2006-11-08 Tecnobiomedica S.p.A. Method of preparing acellularized, biocompatible, implantable material
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
KR101420585B1 (en) 2005-08-26 2014-07-17 리전츠 오브 더 유니버스티 오브 미네소타 Decellularization and recellularization of organs and tissues
WO2007056547A2 (en) * 2005-11-08 2007-05-18 Georgia Tech Research Corporation Acellularized biomaterial from embryonic stem cells
US20160082153A1 (en) * 2006-01-18 2016-03-24 Cormatrix Cardiovascular, Inc. Method and System for Treatment of Damaged Biological Tissue
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
AU2013203210B2 (en) * 2006-10-06 2015-05-28 Celularity Inc. Native (telopeptide) placental collagen compositions
CA2665369C (en) 2006-10-06 2023-01-10 Anthrogenesis Corporation Human placental collagen compositions, and methods of making and using the same
EP2079490B1 (en) 2006-10-23 2012-08-29 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
CZ301086B6 (en) * 2007-10-17 2009-11-04 Bio-Skin, A. S. Sterile autogenous, allogenic or xenogenic implant and process for preparing thereof
EP2319548B1 (en) * 2008-08-14 2016-06-01 KCI Licensing, Inc. Tissue scaffolds
US20120064537A1 (en) * 2010-06-30 2012-03-15 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
EP2611472B1 (en) 2010-09-01 2016-02-10 Regents of the University of Minnesota Methods of recellularizing a tissue or organ for improved transplantability
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
EP4190285A1 (en) 2011-01-06 2023-06-07 Humacyte, Inc. Tissue-engineered constructs
AU2012262311B2 (en) 2011-05-31 2016-04-28 Lifecell Corporation Adipose tissue matrices
EP2805164B1 (en) * 2012-01-16 2017-11-08 Koninklijke Philips N.V. Determining a presence of target molecules in a body fluid comprising cells
ES2716993T3 (en) 2012-03-08 2019-06-18 Lifecell Corp Matrices of collagen and tissue activated by enzymes
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
EP2869861B1 (en) 2012-07-05 2018-04-11 Lifecell Corporation Tissue-based drain manifolds
CN103536967B (en) * 2012-07-10 2016-04-13 上海微创医疗器械（集团）有限公司 A kind of method for removing cells preparing extracellular matrix support material
CA2878446A1 (en) 2012-07-13 2014-01-16 Lifecell Corporation Methods for improved treatment of adipose tissue
ES2849440T3 (en) 2012-09-26 2021-08-18 Lifecell Corp Processed adipose tissue
WO2014110586A1 (en) * 2013-01-14 2014-07-17 Florida State University Research Foundation, Inc. Extracellular matrix derived from stem cells and methods for production
KR20230061578A (en) 2013-03-15 2023-05-08 미로매트릭스 메디칼 인크. Use of perfusion decellularized liver for islet cell recellularization
CN104353115B (en) * 2014-10-29 2016-06-01 南通大学附属医院 Take off the test kit of cytoskeleton, the preparation of support for pancreas and plant method for planting again
CN105013014A (en) * 2015-07-31 2015-11-04 武汉蓝普医品有限公司 Preparation method and application of acellular matrix biological material
CN105920670A (en) * 2016-05-19 2016-09-07 李世荣 Degradable male genital organ patch composite material with biological elasticity and preparation method thereof
CA3027505A1 (en) 2016-06-15 2017-12-21 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
ES2841427T3 (en) 2016-07-05 2021-07-08 Lifecell Corp Tissue matrices incorporating multiple tissue types
WO2018048899A1 (en) 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
CA3065498A1 (en) * 2017-05-30 2018-12-06 Adeka Corporation Method for producing decellularized material for transplantation and graft composition consisting of biocompatible material including said material
CN107596446B (en) * 2017-09-16 2020-07-28 温州医科大学 Decellularization kit for maintaining tissue ultrastructure and nutrition microenvironment
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
WO2019079570A1 (en) 2017-10-18 2019-04-25 Lifecell Corporation Adipose tissue products and methods of production
ES2960617T3 (en) 2017-10-19 2024-03-05 Lifecell Corp Fluid Acellular Tissue Matrix Products and Production Methods
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US12263275B2 (en) 2018-06-13 2025-04-01 Miromatrix Medical Inc. Fistula filler and deployment system
CN110876816A (en) * 2018-09-06 2020-03-13 韩嫣 Pig bladder source bioactive repair material
EP3976127B1 (en) 2019-05-30 2025-09-24 LifeCell Corporation Biologic breast implant
CN111569151B (en) * 2020-05-12 2021-12-17 上海亚朋生物技术有限公司 Acellular dermal matrix tissue engineering scaffold and preparation method thereof
CN111938885A (en) * 2020-08-25 2020-11-17 北京佰仁医疗科技股份有限公司 A kind of artificial biological bile duct and its preparation method and application
US11998662B1 (en) 2021-06-09 2024-06-04 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
US12383657B1 (en) 2021-06-09 2025-08-12 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
DE69210225T2 (en) * 1991-02-14 1996-12-05 Baxter Int Manufacturing process for flexible biological tissue transplant materials
AU5564996A (en) * 1995-04-19 1996-11-07 St. Jude Medical Inc. Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization

Also Published As

Publication number Publication date
WO2002040630A3 (en) 2004-06-10
IL139708A0 (en) 2002-02-10
WO2002040630A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2002224003A1 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
PT1231887E (en) Method and composition for the treatment of scars
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
EP1416044A4 (en) Support for cell / tissue culture and culture method
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2001255767A1 (en) Methods and reagents for tissue engineering of cartilage in vitro
AU2001292917A1 (en) Method of preparing and processing transplant tissue
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AUPR211400A0 (en) Material and method for treatment of timber
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU2786100A (en) Method of selecting transformed cells and tissues
AU2002230459A1 (en) Cell culture apparatus and methods of use
AU3205801A (en) Method and composition for promoting hair growth
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2001246763A1 (en) A preparation method for a porous framework used in the prostheses of tissue andorgans
AU2001217686A1 (en) Method of establishing cultures of human dendritic cells and use thereof
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU2000240061A1 (en) Tissue compositions using cultured fibroblasts and keratinocytes and methods of use thereof
AU2001280299A1 (en) Improvements in and relating to methods and apparatus for the application of honey to wounds
AU2002230479A1 (en) Cell culture apparatus and methods of use
HUP0102002A3 (en) Biologically active composition and process for its preparation
AU2002241691A1 (en) Biologically active composites and methods for their production and use
AU2001236064A1 (en) Method for analysis of substances in tissue or in cells